Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

download Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

of 27

Transcript of Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    1/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` =

    M Uylg`c{ y`uly{Ln

    [L S[PK_ [A@ UYLIB@D LF N@Z UYLKPC[ DMYH@[ONJ ON

    UAMYDMC@P[OCMBS ONKPS[Y_

    ULS[ JYMKPM[@ KOUBLDM ON DMNMJ@D@N[

    Pnk`y {a` Jpokmnc` lf

    Dy.N``ymg Cam{{`yg`` Dy.M.H.[ldmyY`jolnmb Ipson`ss Dmnmj`y Fmcpb{ lfDmnmj`d`n{!Fly P{{mymhamnk/ Klln Ipson`ssScallbMv`n{os Uamydm B{k. K`aymkpn

    SPIDO[[@K I_Uymk``u

    UJKD !95=5$=9 Im{ca/Klln Ipson`ss ScallbK`aymkpn

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    2/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` 9

    CLN[@N[S

    Ilnmfo`k C`y{ofocm{` ......................................................................................................... 3

    @q`cp{ov` Spddmy ....................................................... @yyly- Illhdmyh nl{ k`fon`k.

    On{ylkpc{oln ...................................................................................................................... 0

    Lig`c{ov` lf {a` Uylg`c{ .................................................................................................... 6

    Cldumn Uylfob` .............................................................................................................. :

    Vosoln mnk Dossoln s{m{`d`n{ ........................................................................................ =9

    Uylkpc{ Ymnj` ................................................................................................................ =3

    Szl{ Mnmbsos ................................................................................................................. =0

    Dmyh`{onj ,N`z Uylkpc{ Dmyh`{onj Uylib`ds .............................................................. =6

    Spjj`s{oln Fly N`z Uylkpc{ Dmyh`{onj ........................................................................ =:Clncbpsoln ...................................................................................................................... =1

    Ioiboljymua .................................................................................................................. =?

    ]P@S[OLNNMOY@ ....................................................................................................... 95

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    3/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` 3

    C@Y[OFOCM[@7

    [aos os {l c`y{of {am{ O md Uymk``u" cpyy`n{b m 3yk [yod`s{`y s{pk`n{ lf {a` clpys` UJKD"ams spcc`ssfpbb cldub`{`k d uylg`c{ [L S[PK_ [A@ UYLIB@D LF N@Z UYLKPC[DMYH@[ONJ ON UAMYDMC@P[OCMBS ONKPS[Y_

    [amnhonj _lp"

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    4/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` ;

    @Q@CP[OV@ SPDDMY_

    Z` hnlz {am{ Smnlfo$Mv`n{os Uamydmc`p{ocmbs amv` dly` {amn 00 `mys lf o{s

    `qos{`nc`. Pu {obb 955? o{ ams jln` {aylpja dmn camnj`s ms fmy ms o{s

    clddpnocm{oln mnk dmyh`{onj d`{alklblj os clnc`yn`k.

    O{ ams i``n y`jpbmy {l pukm{` o{s`bf ms u`y bm{`s{ clnc`yn i` o{ {`canlblj ly

    `nvoylnd`n{mb.

    [a` y`c`n{ camnj` on o{s clddpnocm{oln d`{alklblj os kyovonj zo{a {a`

    vmbp`s lf @clbljocmb clnc`yn. O{ os {yonj {l m{{ymc{ cps{ld`ys {lzmyks dly`

    pukm{`k mnk cbls` lf `clblj {`canlblj zo{a i`s{ on o{s cbmss fpnc{olnmbo{o`s

    & vmbp` fly dln`.

    [a` flbblzonj mnmbsos ams `nmib`k ps {l pnk`ys{mnk {a` flbblzonjs

    =. Dmyh`{onj S{ym{`j

    9. N`z uylkpc{ k`v`blud`n{ s{ym{`j

    3. D`kom V`aocb`

    ;. D`kom Ubmnnonj & Ipkj`{ Mbblcm{oln

    S{ym{`jo`s fly d`mspyonj {a` `ff`c{ov`n`ss lf {a` cmdumojn.

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    5/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` 0

    ON[YLKPC[OLN

    LV@YVO@Z LF UAMYDMC@P[OCMB S@C[LY7

    Mcclpn{onj fly {zl u`yc`n{ lf {a` zlybk*s uamydmc`p{ocmb dmyh`{" {a` Onkomnuamydmc`p{ocmb s`c{ly ams mn `s{odm{`k dmyh`{ vmbp` lf milp{ PS +1 iobboln. O{*s m{;{a ymnh on {`yds lf {l{mb uamydmc`p{ocmb uylkpc{oln mnk =3{a on {`yds lf vmbp`. O{os jylzonj m{ mn mv`ymj` ym{` lf :.9 % mnk os `qu`c{`k {l jylz {l PS + =9 iobbolni 95=5.

    Lv`y {a` bms{ {zl `mys {a` uamydmc`p{ocmb dmyh`{ vmbp` ams oncy`ms`k {l milp{

    PS + 300 dobboln i`cmps` lf {a` bmpnca lf n`z uylkpc{s. Mcclykonj {l mn `s{odm{`"3?55 n`z j`n`yoc uylkpc{s amv` i``n bmpnca`k on {a` ums{ {zl `mys. [a`s` amv`i``n i mnk bmyj` bmpnca`k i ioj iymnks on {a` uamydm s`c{ly. Mnk on {a` `my9550 Onkomn uamydmc`p{ocmb cldumno`s cmu{py`k mylpnk :5% lf {a` kld`s{ocdmyh`{.

    Ms on {a` uy`s`n{ sc`nmyol" lnb m f`z u`lub` cmn mfflyk cls{b kypjs" zaoca amv`oncy`ms`k uyoc` s`nso{ovo{ on {a` uamydmc`p{ocmb dmyh`{. Nlz {a` cldumno`s my`{yonj {l cmu{py` {a` dmyh`{ i on{ylkpconj aoja }pmbo{ mnk blz uyoc` d`kocon`smnk kypjs.

    Zo{a {a` Uylkpc{ Um{`n{ Mc{" zaoca cmd` on{l mc{oln on Gmnpmy 9550" {aos onkps{yos mib` {l m{{ymc{ ioj DNCs {l Onkom. @mybo`y {a`s` ioj foyds amk muuy`a`nsolns onbmpncaonj n`z kypjs on {a` Onkomn dmyh`{.

    M{ uy`s`n{" m bmyj` npdi`y lf Onkomn uamydmc`p{ocmbs cldumno`s my` bllhonj fly{o`$pus zo{a fly`ojn foyds fly on$boc`ns` kypjs. JbmqlSdo{aHbon` os mdlnj {a` {lucaloc`s fly {a` foyds {am{ zosa {l bmpnca {a`oy uylkpc{ on Onkom" ip{ kl nl{ amv` mniymnca lv`y a`y`.

    Cln{ymc{ y`s`myca mnk uamydmc`p{ocmb lp{slpyconj my` {a` n`z mv`np`s on {a`uamydmc`p{ocmb dmyh`{. Cln{ymc{ dmnpfmc{pyonj os jylzonj m{ m v`y fms{ umc` mnk

    os `s{odm{`k {l jylz {l PS +35iobboln" za`y`ms cln{ymc{ y`s`myca os `s{odm{`k {ly`mca PS+6$=5 iobboln.

    Onkomn dpb{onm{olnmb cldumno`s boh` Ky.Y`kk*s Bmi" Coubm" Ymnimq" `{c amv`cy`m{`k mzmy`n`ss milp{ {a` Onkomn dmyh`{ uylsu`c{s on {a` on{`ynm{olnmbuamydmc`p{ocmb dmyh`{. Muuylvmbs jov`n i Fllks mnk Kypjs Mkdonos{ym{oln!FKM/ mnk MNKM !Miiy`vom{`k N`z Kypj Muubocm{oln/,KDF !Kypj Dms{`y Fob`/amv` ubm`k mn oduly{mn{ ylb` on dmhonj Onkom m cls{`ff`c{ov` mnk aoja }pmbo{

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    6/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` 6

    uylkpc{ dmnpfmc{py`y. Fpy{a`ydly`" {a` camnj`s {am{ {llh ubmc` on {a` um{`n{ bmz"camnj` lf uylc`ss um{`n{ {l uylkpc{ um{`n{" amv` a`bu`k on y`kpconj {a` yosh lfblss fly on{`bb`c{pmb uylu`y{.

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    7/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` :

    LIG@C[OV@ LF [A@ UYLG@C[

    [a` lig`c{ov` lf {a` uylg`c{ os7

    [l hnlz {a` mzmy`n`ss milp{ Smnlfo$Mv`n{os N`z Uylkpc{ mdlnj {a` u`lub` lfP{{mymhamnk.

    [l hnlz {a` uy`f`y`nc`s lf {``n mjy`` y`jmykonj Smnlfo$Mv`n{os N`z Uylkpc{. [l hnlz {a` psmj` um{{`yn lf Smnlfo$Mv`n{os N`z uylkpc{ on vmyolps upyuls`s. [l fonk lp{ {a` vmyolps s{ym{`jo`s `dubl`k i {a` cldu`{onj iymnks {l oncy`ms`

    {a` smb`s lf {a`oy uylkpc{.

    [l hnlz {a` dls{ mcc`u{mib` iymnk i clnspd`ys.

    Sclu` lf S{pk

    [a` y`s`myca a`bus on k`mbonj zo{a clnspd`ys. Fp{py` y`s`myca`s nm ps` o{ ms m s`clnkmy slpyc` lf km{m. O{ uylvok`s v`y ps`fpb onflydm{oln milp{ psmj` i`amvolys lf {a` Smnlfo$Mv`n{os

    n`z uylkpc{ iymnk. [a` y`s`myca y`uly{ clpbk i` fpy{a`y ps`k i d` on fp{py` fly mkvmnc`k y`s`myca

    ln {a` {luoc.

    Bodo{m{oln

    [a` my`m clv`y`k i d` zms v`y v`y sdmbb {am{ os lnb K`aymkpn. Clnspd`ys z`y` nl{ mzmy` milp{ {a` `n{oy` n`z uylkpc{s lf Smnlfo$Mv`n{os

    Uamydmc`p{ocmbs. [a`y` z`y` nl{ `nlpja umymd`{`ys ly {a` s{pk dm{`yomb mvmobmib` fly {a`

    on{`yuy`{m{oln lf {a` y`spb{ sl ms {l y`mca {l m fonmb clncbpsoln.

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    8/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` 1

    CLDUMN_ UYLFOB@

    SMNLFO$MV@N[OS

    955? smb`s7 9?.3 iobboln

    M iylmk uly{flbol lf uamydmc`p{ocmb uylkpc{s7Uy`scyou{oln d`kocon`s" clnspd`y a`mb{acmy` !L[C/ mnk j`n`yocs

    Zlybk b`mk`y on vmccon`s !Dmyh`{ samy` fyld smnlfo ums{`py on{`ynmb `s{odm{`s m{

    `nk K`c`di`y 955? ims`k ln m jblimb uy`s`nc`" oncbpkonj 05% lf smb`s fyld {a`Smnlfo Ums{`py DSK glon{ v`n{py`/

    Uy`s`nc` mcylss il{a {ymko{olnmb mnk `d`yjonj dmyh`{s

    Dly` {amn =55"555 `dubl``s on lv`y =55 clpn{yo`s.

    Flcps`k ln um{o`n{s n``ks" smnlfo $mv`n{os lff`ys m ymnj` lf `ss`n{omb a`mb{acmy`mss`{s" oncbpkonj m iylmk$ims`k uylkpc{ uly{flbol mnk m uy`s`nc` zlybkzok`.Smnlfo$mv`n{os uylkpc{s mnk s`yvoc`s my` c`n{`y`k ln um{o`n{s.

    Mdio{oln7 {l i`cld` m kov`ysofo`k jblimb a`mb{acmy` b`mk`y.

    Smnlfo $mv`n{os s{ym{`j os ipob{ mylpnk {ay`` uyolyo{o`s {l y`mca o{s jlmbs mnk`nspy` sps{monmib` jylz{a7

    Oncy`msonj onnlvm{oln on Y`s`myca mnk K`v`blud`n{

    Mkmu{onj Jylpu s{ypc{py`s {l fp{py` cambb`nj`s

    S`owonj `q{`ynmb jylz{a luuly{pno{o`s.

    Fmc{s Salzonj Jylz{a sc`nmyol7

    Smnlfo$mv`n{os os m jblimb a`mb{acmy` cldumn `njmj`k on {a` y`s`myca"k`v`blud`n{" dmnpfmc{py` mnk dmyh`{onj lf a`mb{acmy` uylkpc{s. Lpyipson`ss os kov`ysofo`k mnk oncbpk`s uamydmc`p{ocmbs clduyosonj Yq!uy`scyou{oln/ kypjs" clnspd`y a`mb{acmy` ipson`ss !lv`y${a`$clpn{`y ,cldion`k L[C mnk Yq kypjs/ mnk j`n`yocs8 vmccon`s mnk mnodmb a`mb{a.

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    9/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` ?

    955? n`{ smb`s7 9?"356 dobboln" (6.3% v`ysps 9551.

    955? mkgps{`k @US `qcbpkonj s`b`c{`k o{`ds7 6.;?" (=1.9% v`ysps 9551 ly(=3.=% m{ clns{mn{ ,+ `qcamnj` ym{`.

    Uamydmc`p{ocmbs ipson`ss

    Smnlfo$mv`n{os* uamydmc`p{ocmbs ipson`ss flcps`s ln soq {a`ymu`p{oc my`ms7komi`{`s"lnclblj" {ayldilsos" cmykolvmscpbmy kos`ms`s" c`n{ymb n`yvlps ss{`d !CNS/ mnkon{`ynmb d`kocon`.

    955? n`{ smb`s lf {a` uamydmc`p{ocmbs ipson`ss7 90"193 dobboln" (3.:%v`ysps 9551. [a` Yq kypjs mc{ovo{ clpn{s 1 fbmjsaou uylkpc{s on 955? 7 Bmn{ps"Blv`nlq" Ubmvoq" [mql{`y`" Muylv`b" @blqm{on" Muokym" Dpb{m}.

    Fbmjsaou uylkpc{s

    Dobbolns lf `pyls955? n`{ smb`s

    Camnj` m{clns{mn{

    `qcamnj` ym{`s

    Bmn{ps 3"515 (99.0%

    Blv`nlq 3"5;3 (1.1%Ubmvoq 9"693 (5.9%[mql{`y` 9"=:: (6.=%Muylv`b ="936 (;.:%@blqm{on ?0: $3;.:%Muokym =3: (31.1%Dpb{m} 90 $

    Nl{`7 Zlybkzok` uy`s`nc` lf Ubmvoq os 6":19 dobboln" (6.9%. Zlybkzok`uy`s`nc` lf

    Muylv`b os 9"5=9 dobboln" (=.:%.

    Smnlfo$mv`n{os mbsl ams m sojnofocmn{ uy`s`nc` on clnspd`y a`mb{acmy` ipson`ss"on vmyolps uylkpc{ cm{`jlyo`s.

    955? n`{ smb`s lf clnspd`y a`mb{acmy`7 =";35 dobboln" (96.1% v`ysps 9551.On mkko{oln {l Yq kypjs mnk clnspd`y a`mb{acmy`" {a` uamydmc`p{ocmb ipson`ssclduyos`s j`n`yocs.

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    10/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` =5

    955? n`{ smb`s lf j`n`yocs7 =.5=9 dobboln.[a` {pynlv`y lf {a` j`n`yocs mc{ovo{muuylqodm{`b {youb`k cldumy`k {l 9551" dmonb y`fb`c{onj {a` clnslbokm{oln lfW`n{ovm" H`nkyoch mnk D`kb` zo{a lyjmnoc jylz{a.

    Smnlfo Mv`n{os

    Smnlfo Mv`n{os zms flyd`k on 955; za`n Smnlfo$Sn{abmil mc}poy`k Mv`n{os. On`myb 955;" Smnlfo$Sn{abmil dmk` m als{ob` {mh`lv`y iok zly{a ;:.1 in flyMv`n{os. Ono{ombb" Mv`n{os y`g`c{`k {a` iok i`cmps` o{ f`b{ {am{ {a` iok lff`y`k onf`yolyvmbp` ims`k ln {a` cldumn*s samy` vmbp`. [a` {ay``dln{a {mh`lv`y im{{b`clncbpk`k za`n Smnlfo$Sn{abmil bmpnca`k m fyo`nkb iok lf 0;.0 in on ubmc` lf

    {a` uy`volpsb y`g`c{`k als{ob` iok. Fy`nca jlv`ynd`n{ on{`yv`n{oln mbsl ubm`k mnmc{ov` ylb`. [a` Fy`nca lv`ynd`n{" k`soyonj zam{ {a` cmbb`k m )blcmb slbp{oln)" up{a`mv uy`sspy` ln Smnlfo$ Sn{abmil {l ymos` o{s iok fly Mv`n{os mf{`y o{ i`cmd`hnlzn {am{ Nlvmy{os" m Szoss uamydmc`p{ocmb cldumn" zms on {a` ypnnonj.

    Smnlfo$Sn{abmil

    Smnlfo$Sn{abmil zms flyd`k on =??? za`n Smnlfo !flyd`y spisokomy lf [l{mb/d`yj`k zo{a Sn{abmil !flyd`y spisokomy lf B*Lymb/. [a` d`yj`k cldumn zmsims`k on Umyos" Fymnc`.

    Clnnmpja{ Cmdups

    [a` Cmnmkomn lu`ym{olns lf Smnlfo$Mv`n{os i`jmn ms Clnnmpja{Bmilym{lyo`s,Clnnmpja{ D`kocmb Y`s`myca Bmilym{lyo`s lf {a` Pnov`yso{ lf[lyln{l fyld =?=; {l =?:9. O{ zms upycams`k i f`k`ymb jlv`ynd`n{*s CmnmkomnK`v`blud`n{ Clyulym{oln mnk bm{`y uyovm{ow`k. Slbk {l {a` Fy`nca Ons{o{p{ Dyo`pqon =?1? mnk y`nmd`k Ums{`py D`yo`pq Clnnmpja{. M s`yo`s lf d`yj`ys zlpbkflbblz mnk {a` Cmnmkm pno{ zms y`nmd`k )Clnnmpja{ Cmdups) lf Mv`n{osUms{`py. O{ os nlz {a` Cmnmkomn pno{ lf Smnlfo Ums{`py mnk umy{ lf {a` Smnlfo$Mv`n{os `duoy`.

    Mv`n{os

    Mv`n{os zms flyd`k on =??? za`n Yan`$Ulpb`nc S.M. d`yj`k zo{a Al`cas{DmyolnYlpss`b" zaoca o{s`bf zms flyd`k fyld {a` d`yj`y lf Al`cas{ MJ zo{a Ylpss`bPcbmf mnk Dmyoln D`yy`bb Klz. [a` d`yj`k cldumn zms ims`k on Scaob{oja`od"n`my S{ymsilpyj" Fymnc`

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    11/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` ==

    Smnlfo$Mv`n{os on ONKOM

    On Onkom" smnlfo$mv`n{os lu`ym{`s {aylpja {zl `n{o{o`s $ Mv`n{os Uamydm Bodo{`k mnkSmnlfo$ Sn{a`bmil !Onkom/ Bodo{`k. Smnlfo$mv`n{os mnk o{s =55% spisokomyAl`cas{ JdiA" my` {a` dmgly samy`albk`ys lf Mv`n{os Uamydm Bodo{`k mnk{lj`{a`y albk 05.=9% lf o{s umok$pu samy` cmuo{mb. Smnlfo$Sn{a`bmil !Onkom/Bodo{`k os m =55% spisokomy lf smnlfo$mv`n{os.

    Mv`n{os Uamydm Bodo{`k zms onclyulym{`k on Dm =?06 pnk`y {a` nmd` Al`cas{

    F`kcl Uamydm Uyovm{` Bodo{`k. Lv`y {a` `mys" o{s nmd` zms camnj`k {l Al`cas{Uamydmc`p{ocmbs Uyovm{` Bodo{`k" Al`cas{ Onkom Bodo{`k mnk Al`cas{ DmyolnYlpss`b Bodo{`k. [a` samy`s lf Mv`n{os Uamydm Bodo{`k my` }pl{`k ln {a`Ildim S{lch @qcamnj` mnk {a` Nm{olnmb S{lch @qcamnj`.

    On Onkom" Mv`n{os Uamydm Bodo{`k ams ="1;5 `dubl``s. O{ ams s{m{`$lf${a`$my{dmnpfmc{pyonj fmcobo{o`s on Mnhb`sazmy mnk Jlm" za`y` mc{ov` uamydmc`p{ocmbonjy`ko`n{s mnk flydpbm{olns my` dmnpfmc{py`k.

    Smnlfo$Sn{a`bmil !Onkom/ Bodo{`k zms onclyulym{`k on Gpn` =??6 pnk`y {a` nmd`Smnlfo [lyy`n{ !Onkom/ Uyovm{` Bodo{`k. O{s nmd` zms camnj`k {l Smnlfo$Sn{a`bmil!Onkom/ Bodo{`k on Dm 9559. Smnlfo$Sn{a`bmil !Onkom/ Bodo{`k ams mylpnk 9:0`dubl``s.

    [a` {zl cldumno`s amv` y`jos{`y`k lffoc`s on Dpdimo mnk wlnmb lffoc`s onDpdimo" Ca`nnmo" Hlbhm{m mnk N`z K`bao.

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    12/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` =9

    H@_ @Q@CP[OV@

    Dy. Cayos Vo`aimca`y "Cao`f @q`c. Lffoc`y" Dmnmjonj Koy`c{ly"Koy`c{ly mnk D`di`y lf S{ym{`j Clddo{{``

    Dy. Noj`b Iyllhsi "Camoydmn lf Smnlfo$Mv`n{os PH"

    Dmnmjonj Koy`c{ly lf Smnlfo$Mv`n{os PH mnk J`n. Dmnj. lf Jylpu PH

    Dy. G`ydl` Cln{mdon` "Cao`f Fonmncomb Lffoc`y mnk @q`c. VU

    Dy. Jobb`s Ba`ynlpbk "Sy. VU lf AY" D`di`y lf {a` Dmnmj`d`n{ Clddo{{``

    Dy. S{`v` Lbkfo`bk "Cao`f @q`c. Lffoc`y lf PH Lu`ym{olns"Koy`c{ly lf Cldd`ycomb Lu`ym{olns $ PH mnk J`n. Dmnj. lf Smnlfo $ Mv`n{os PH

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    13/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` =3

    VOSOLN LF [A@ CAO@F @Q@CP[OV@ LFFOC@Y

    CAYOS[LUA@Y VO@AIMCA@Y"

    CAO@F @Q@CP[OV@ LFFOC@Y

    Ov` kosclv`y`k v`y slbok flpnkm{olns mnk dmn pnk`y$muuy`com{`k mss`{s {am{ Ozmn{ {l {mbh milp{. Dls{ lf lpy cldu`{o{lys sm {a` zmn{ {l y`kpc` {a`oy y`bomnc`ln sdmbb dlb`cpb`s on {a` k`v`blu`k zlybk. Z`v` mby`mk kln` {aos. Of lp bllh m{{a` j`ljymuaoc iy`mhklzn lf lpy smb`s" mylpnk m {aoyk os j`n`ym{`k on Nly{aMd`yocm" sboja{b dly` {amn ;5% on @pylu` mnk m }pmy{`y on l{a`y clpn{yo`s. Z`my` mby`mk {a` b`mk`y on `d`yjonj dmyh`{s" m cb`my my`m lf fp{py` jylz{a. Z` my`

    mbsl b`mk`y on vmccon`s !=/" zo{a dmgly uylkpc{s y`mk {l mkky`ss dmgly upiboca`mb{a cambb`nj`s. [aos ipson`ss mc{ovo{ os b`ss odumc{`k i j`n`yocs kp` {l {a`sojnofocmn{ b`v`bs lf `qu`y{os` mnk onv`s{d`n{ y`}poy`k. Mnk lpy clnspd`ya`mb{acmy` !L[C/ ipson`ss" ymnh`k soq{a zlybkzok` !9/ os mn `qc`bb`n{ imsos flyfpy{a`y k`v`blud`n{.

    Lpy s{ylnj fonmncomb ulso{oln os mnl{a`y h` mss`{ on m {od` lf jblimb `clnldoccyosos. Z` amv` m s{ylnj cmsa fblz" jovonj ps {a` s{ym{`joc fb`qoiobo{ {l fonk mnks`ow` n`z jylz{a luuly{pno{o`s. Smnlfo $Mv`n{os os z`bb `}pouu`k {l fmc` {a` fp{py`.

    Lpy mdio{oln os {l i`cld` m kov`ysofo`k jblimb A`mb{acmy` b`mk`y" flcps`k lnum{o`n{s n``ks

    A`mb{acmy` b`mk`y" flcps`k ln um{o`n{s n``ks

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    14/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` =;

    VOSOLN MNK DOSSOLN LF SMNLFO MV@N[OS

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    15/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` =0

    Uylkpc{ Ymnj`

    Mdmyb !jbod`uoyok`/

    Mdmyb D !jbod`uoyok`"

    d`{flydon `q{`nk`k y`b`ms`/

    Mdmyb DU !jbod`uoyok`" d`{flydon"

    uoljbo{mwln` `q{`nk`k y`b`ms`/

    Muokym !onspbon jbpboson`/

    C`{muon U !d`{flydon"

    uoljbo{mwln` `q{`nk`k y`b`ms`/

    C`{muon QY !d`{flydon `q{`nk`k y`b`ms`/

    Kmlnob !jboi`ncbmdok`/

    Kmlnob D !jboi`ncbmdok`"

    d`{flydon `q{`nk`k y`b`ms`/

    Cldiofbmd

    Cldiofbmd Cy`md !d`{ab smbocbm{`"

    d`n{alb & cmdualy/

    Mvob !ua`noymdon` dmb`m{`/

    Mbb`jym !f`qlf`nmkon` akylcablyok`/

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    16/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` =6

    SZL[ LF SMNLFO $MV@N[OS

    S[Y@NJ[A7

    Jllk dmyh`{ ulso{oln lf iblchips{`y kypjs.Jllk Fy`nca cpb{py`,imchjylpnk

    Z@MHN@SS7

    Y`bm{ov` sdmbb dmyh`{ samy` !0 %/ cldumy`k {l Ufow`y!=5.?%/Smd` onfyms{ypc{py` on dmn clpn{yo`s.

    LUUPY[PNO[_7

    Jllk Dmyh`{ Ulz`y.@clnldo`s lf scmb`, Y&KSn`yjo`s on mkdonos{ym{oln.Dmn k`v`blud`n{s cmnnl{ i` fonmnc`k zo{alp{ d`yj`y.

    [AY@M[S7

    Kos`clnldo`s lf scmb` kp` {l {a` iylmk`y lyjmnowm{oln mnkCldubocm{`k clddpnocm{olns.

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    17/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` =:

    Dmyh`{onj,n`z uylkpc{ $ dmyh`{onj uylib`ds

    =. ??% lf {myj`{ mpko`nc` !{lpyos{s/ amv` nl ok`m {a` uylkpc{s `qos{s9. ??% lf u`lub` zal voso{ {a` Ca`dos{ salus kln*{ nl{oc` {a` uylkpc{ ln {a` sa`bv`s ly on

    m kosubm zonklz.

    3. ??% lf u`lub` zal nl{oc` {a` uylkpc{ amv` nl ok`m zam{ os {am{

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    18/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` =1

    Spjj`s{oln fly N`z Uylkpc{ Dmyh`{onj

    Cy`m{` {a` mzmy`n`ss lf {a` n`z uylkpc{ on {a` Dmyh`{. Ps` cmdumojnonj fly dmyh`{onj. Ps` fy`` smdub` i`fly` bmpnca`k {a` uylkpc{. Myymnj` {a` umy{ fly klc{lys. Jov` sld` su`comb umchmj` {l {a` fo`bk s{mff. Ps` mkv`y{osonj fly dmyh`{onj.

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    19/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` =?

    CLNCBPSOLN

    [amnh lp

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    20/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` 95

    IOIBOLJYMUA_

    Illhs7Dmyh`{onj Dmnmj`d`n{" Uaobou Hl{b`y

    Y`s`myca D`{alklblj I C.Y Hl{amyoS{ym{`joc Dmyh`{onj Dmnmj`d`n{ I Zobsln Jobbojmn

    Z`iso{`s7a{{u7,,zzz.smnlfo$mv`n{os.clda{{u7,,zzz.jlljb`.clda{{u7,,zzz.zohou`kom.cld

  • 8/2/2019 Marketing Problem Faced by the Pharma Industry Like Aventis Pharma

    21/27

    Uymk``u UJKD 3YK [yod`s{`y Umj` 9=

    UAMYDMC@P[OCMB UYLKPC[ ]P@S[OLNNMOY@

    Jblimb Kypj Fmcobo{ !JKF/

    O. Uylkpc{ ok`n{ofocm{oln

    Mc{ov` Uamydmc`p{ocmb Onjy`ko`n{!s/ !ps` ONN of mn/7

    ..

    J`n`yoc nmd` lf {a` uylkpc{7

    ......

    [ymk` nmd` !of mn/7

    Klsmj` flyd7\[mib`{s\Cmuspb`s\Ong`c{mib` \Sypus,lymb bo}poks\L{a`y7S{y`nj{a u`y klsmj` pno{7

    ..

    Ylp{` lf mkdonos{ym{oln7\Lymb\O.D.\O.V.\S.C.\L{a`yUmch sow` mnk k`scyou{oln lf uyodmy umchmjonj dm{`yombs !oncbpkonj cln{mon`y,cblspy` ss{`d mnk

    k`{mobs lf dm{`yombs

    cldulso{oln/7

    ..

    Umch sow` mnk k`scyou{oln lf s`clnkmy umchmjonj dm{`yombs !oncbpkonj cln{mon`y,cblspy` ss{`d

    mnk k`{mobs lf

    dm{`yombs cldulso{oln/7

    ..

    Fly umy`n{`ymb uylkpc{s" mbb clduln`n{s zaoca dm i` on cln{mc{ zo{a {a` uylkpc{ cldub zo{a

    y`}poy`d`n{s su`cofo`k

    i IU" @U"PSU